Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07524335
PHASE3
Aspirin in Subclinical Coronary Artery Disease: A Pilot Randomised Controlled Trial
Sponsor: Montreal Heart Institute
View on ClinicalTrials.gov
Summary
In patients with subclinical coronary artery disease, the ASCAD-P study aims to assess the feasibility of a larger phase 3 pragmatic randomized controlled trial comparing prescription versus no prescription of low-dose aspirin in routine clinical practice.
Key Details
Gender
All
Age Range
40 Years - Any
Study Type
INTERVENTIONAL
Enrollment
48
Start Date
2026-05-01
Completion Date
2028-05-01
Last Updated
2026-04-15
Healthy Volunteers
No
Interventions
DRUG
Prescription of Aspirin
Aspirin 81 mg orally once daily
DRUG
No prescription
No prescription of aspirin 81 mg orally once daily
Locations (1)
Montreal Heart Institute
Montreal, Quebec, Canada